GIVN Givaudan SA
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.…
Industry Peers
Specialty ChemicalsKey Statistics
About Givaudan (SWX: GIVN)
›
Givaudan (SWX: GIVN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 17,508 employees.
The shares were at 4075.00 CHF on 19 November 2026, up 21.2% over 52 weeks. Its 52-week range is 2566.00 CHF to 4137.00 CHF: the price is 1.5% below the high and 58.8% above the low.
At a market capitalisation of 37.42B CHF, it trades at 39.5 times trailing earnings and 29.9 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 32.8, a premium of 20% for GIVN. It pays a dividend yielding 1.76% (it pays out 70% of its earnings), against a median of 1.91% among the dividend payers in that peer group.
Givaudan reports return on equity of 23.6%, an operating margin of 17.9% and revenue down 1.7% year over year.
Its debt exceeds its cash by 4.60B CHF, a debt-to-equity ratio of 0.97. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 18 analysts cover the stock, with an average rating of Hold; their mean price target of 3785.70 CHF is 7.1% below the current price. The next earnings report is expected on 27 January 2027.